341 related articles for article (PubMed ID: 11239157)
1. Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity.
Volchkov VE; Volchkova VA; Muhlberger E; Kolesnikova LV; Weik M; Dolnik O; Klenk HD
Science; 2001 Mar; 291(5510):1965-9. PubMed ID: 11239157
[TBL] [Abstract][Full Text] [Related]
2. RNA Editing of the GP Gene of Ebola Virus is an Important Pathogenicity Factor.
Volchkova VA; Dolnik O; Martinez MJ; Reynard O; Volchkov VE
J Infect Dis; 2015 Oct; 212 Suppl 2():S226-33. PubMed ID: 26138826
[TBL] [Abstract][Full Text] [Related]
3. The nonstructural small glycoprotein sGP of Ebola virus is secreted as an antiparallel-orientated homodimer.
Volchkova VA; Feldmann H; Klenk HD; Volchkov VE
Virology; 1998 Oct; 250(2):408-14. PubMed ID: 9792851
[TBL] [Abstract][Full Text] [Related]
4. Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury.
Yang ZY; Duckers HJ; Sullivan NJ; Sanchez A; Nabel EG; Nabel GJ
Nat Med; 2000 Aug; 6(8):886-9. PubMed ID: 10932225
[TBL] [Abstract][Full Text] [Related]
5. Genomic RNA editing and its impact on Ebola virus adaptation during serial passages in cell culture and infection of guinea pigs.
Volchkova VA; Dolnik O; Martinez MJ; Reynard O; Volchkov VE
J Infect Dis; 2011 Nov; 204 Suppl 3():S941-6. PubMed ID: 21987773
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of guinea pig-adapted variants of Ebola virus.
Volchkov VE; Chepurnov AA; Volchkova VA; Ternovoj VA; Klenk HD
Virology; 2000 Nov; 277(1):147-55. PubMed ID: 11062045
[TBL] [Abstract][Full Text] [Related]
7. Release of viral glycoproteins during Ebola virus infection.
Volchkov VE; Volchkova VA; Slenczka W; Klenk HD; Feldmann H
Virology; 1998 May; 245(1):110-9. PubMed ID: 9614872
[TBL] [Abstract][Full Text] [Related]
8. Ebola Virus GP Gene Polyadenylation Versus RNA Editing.
Volchkova VA; Vorac J; Repiquet-Paire L; Lawrence P; Volchkov VE
J Infect Dis; 2015 Oct; 212 Suppl 2():S191-8. PubMed ID: 25838269
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry.
Takada A; Watanabe S; Ito H; Okazaki K; Kida H; Kawaoka Y
Virology; 2000 Dec; 278(1):20-6. PubMed ID: 11112476
[TBL] [Abstract][Full Text] [Related]
10. Involvement of viral envelope GP2 in Ebola virus entry into cells expressing the macrophage galactose-type C-type lectin.
Usami K; Matsuno K; Igarashi M; Denda-Nagai K; Takada A; Irimura T
Biochem Biophys Res Commun; 2011 Apr; 407(1):74-8. PubMed ID: 21362405
[TBL] [Abstract][Full Text] [Related]
11. Detection and molecular characterization of Ebola viruses causing disease in human and nonhuman primates.
Sanchez A; Ksiazek TG; Rollin PE; Miranda ME; Trappier SG; Khan AS; Peters CJ; Nichol ST
J Infect Dis; 1999 Feb; 179 Suppl 1():S164-9. PubMed ID: 9988180
[TBL] [Abstract][Full Text] [Related]
12. Modulation of virion incorporation of Ebolavirus glycoprotein: effects on attachment, cellular entry and neutralization.
Marzi A; Wegele A; Pöhlmann S
Virology; 2006 Sep; 352(2):345-56. PubMed ID: 16777170
[TBL] [Abstract][Full Text] [Related]
13. Shedding of Ebola Virus Surface Glycoprotein Is a Mechanism of Self-regulation of Cellular Cytotoxicity and Has a Direct Effect on Virus Infectivity.
Dolnik O; Volchkova VA; Escudero-Perez B; Lawrence P; Klenk HD; Volchkov VE
J Infect Dis; 2015 Oct; 212 Suppl 2():S322-8. PubMed ID: 26092855
[TBL] [Abstract][Full Text] [Related]
14. Delta-peptide is the carboxy-terminal cleavage fragment of the nonstructural small glycoprotein sGP of Ebola virus.
Volchkova VA; Klenk HD; Volchkov VE
Virology; 1999 Dec; 265(1):164-71. PubMed ID: 10603327
[TBL] [Abstract][Full Text] [Related]
15. Rescue of Ebola virus from cDNA using heterologous support proteins.
Theriault S; Groseth A; Neumann G; Kawaoka Y; Feldmann H
Virus Res; 2004 Nov; 106(1):43-50. PubMed ID: 15522446
[TBL] [Abstract][Full Text] [Related]
16. GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases.
Volchkov VE; Becker S; Volchkova VA; Ternovoj VA; Kotov AN; Netesov SV; Klenk HD
Virology; 1995 Dec; 214(2):421-30. PubMed ID: 8553543
[TBL] [Abstract][Full Text] [Related]
17. Soluble Glycoprotein Is Not Required for Ebola Virus Virulence in Guinea Pigs.
Hoenen T; Marzi A; Scott DP; Feldmann F; Callison J; Safronetz D; Ebihara H; Feldmann H
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S242-6. PubMed ID: 25957965
[TBL] [Abstract][Full Text] [Related]
18. A new Ebola virus nonstructural glycoprotein expressed through RNA editing.
Mehedi M; Falzarano D; Seebach J; Hu X; Carpenter MS; Schnittler HJ; Feldmann H
J Virol; 2011 Jun; 85(11):5406-14. PubMed ID: 21411529
[TBL] [Abstract][Full Text] [Related]
19. Recovery of infectious human parainfluenza type 2 virus from cDNA clones and properties of the defective virus without V-specific cysteine-rich domain.
Kawano M; Kaito M; Kozuka Y; Komada H; Noda N; Nanba K; Tsurudome M; Ito M; Nishio M; Ito Y
Virology; 2001 May; 284(1):99-112. PubMed ID: 11352671
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of Ebola virus VP24 impairs viral nucleocapsid assembly and prevents virus replication.
Mateo M; Carbonnelle C; Martinez MJ; Reynard O; Page A; Volchkova VA; Volchkov VE
J Infect Dis; 2011 Nov; 204 Suppl 3():S892-6. PubMed ID: 21987766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
